IL-32γ induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 6848-6859

  Jung, Mi Young ^a   Son, Mi Hye ^a   Kim, Soo Hyun ^b   Cho, Daeho ^c   Kim, Tae Sung ^a  

^a Korea University   (South Korea)

^b Konkuk University   (South Korea)

^c Sookmyung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 12; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 23P19; INTERLEUKIN 32; INTERLEUKIN 32GAMMA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHOSPHOLIPASE C; RECOMBINANT INTERLEUKIN 32GAMMA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; IL32 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; IMMUNOMODULATION; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; DRUG EFFECT; HUMAN; IMMUNOLOGY; UPREGULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKINS; MICE; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS; UP-REGULATION;

EID: 79959560825     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003996     Document Type: Article

References (53)

1. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993.
2. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. (Pubitemid 43214587)
3. H17 cells. Nature 448: 484-487.
4. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8: 967-974.
5. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691.
6. Chung, Y., S. H. Chang, G. J. Martinez, X. O. Yang, R. Nurieva, H. S. Kang, L. Ma, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
7. H17 cells in the absence of TGF-β signalling. Nature 467: 967-971.
8. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
9. Oppenheim, J. J., and D. Yang. 2005. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17: 359-365.
10. Yang, D., Q. Chen, S. B. Su, P. Zhang, K. Kurosaka, R. R. Caspi, S. M. Michalek, H. F. Rosenberg, N. Zhang, and J. J. Oppenheim. 2008. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J. Exp. Med. 205: 79-90.
11. + monocytes through distinct pathways that activate NK-κB. J. Immunol. 165: 3647-3655.
12. Nakahara, T., H. Uchi, K. Urabe, Q. Chen, M. Furue, and Y. Moroi. 2004. Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells. Int. Immunol. 16: 1701-1709.
13. Nakahara, T., Y. Moroi, H. Uchi, and M. Furue. 2006. Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J. Dermatol. Sci. 42: 1-11.
14. Palová-Jelínková, L., D. Rozková, B. Pecharová, J. Bártová, A. Sedivá, H. Tlaskalová-Hogenová, R. Spísek, and L. Tucková. 2005. Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. J. Immunol. 175: 7038-7045. (Pubitemid 41598951)
15. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
16. Ito, A., A. Matejuk, C. Hopke, H. Drought, J. Dwyer, A. Zamora, S. Subramanian, A. A. Vandenbark, and H. Offner. 2003. Transfer of severe experimental autoimmune encephalomyelitis by IL-12- and IL-18-potentiated T cells is estrogen sensitive. J. Immunol. 170: 4802-4809. (Pubitemid 36519990)
17. Luger, D., P. B. Silver, J. Tang, D. Cua, Z. Chen, Y. Iwakura, E. P. Bowman, N. M. Sgambellone, C. C. Chan, and R. R. Caspi. 2008. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 205: 799-810.
18. Yoshimura, T., K. H. Sonoda, N. Ohguro, Y. Ohsugi, T. Ishibashi, D. J. Cua, T. Kobayashi, H. Yoshida, and A. Yoshimura. 2009. Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford) 48: 347-354.
19. Yokoi, H., K. Kato, T. Kezuka, J. Sakai, M. Usui, H. Yagita, and K. Okumura. 1997. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12. Eur. J. Immunol. 27: 641-646.
20. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748. (Pubitemid 36227625)
21. Serada, S., M. Fujimoto, M. Mihara, N. Koike, Y. Ohsugi, S. Nomura, H. Yoshida, T. Nishikawa, F. Terabe, T. Ohkawara, et al. 2008. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 105: 9041-9046.
22. Ishihara, K., and T. Hirano. 2002. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13: 357-368.
23. Chen, Y., C. L. Langrish, B. McKenzie, B. Joyce-Shaikh, J. S. Stumhofer, T. McClanahan, W. Blumenschein, T. Churakovsa, J. Low, L. Presta, et al. 2006. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116: 1317-1326.
24. Kang, B. Y., E. Kim, and T. S. Kim. 2005. Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells. Cell. Signal. 17: 665-673.
25. Choi, J. D., S. Y. Bae, J. W. Hong, T. Azam, C. A. Dinarello, E. Her, W. S. Choi, B. K. Kim, C. K. Lee, D. Y. Yoon, et al. 2009. Identification of the most active interleukin-32 isoform. Immunology 126: 535-542.
26. Nold, M. F., C. A. Nold-Petry, G. B. Pott, J. A. Zepp, M. T. Saavedra, S. H. Kim, and C. A. Dinarello. 2008. Endogenous IL-32 controls cytokine and HIV-1 production. J. Immunol. 181: 557-565.
27. Bai, X., S. H. Kim, T. Azam, M. T. McGibney, H. Huang, C. A. Dinarello, and E. D. Chan. 2010. IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J. Immunol. 184: 3830-3840.
28. Shoda, H., K. Fujio, Y. Yamaguchi, A. Okamoto, T. Sawada, Y. Kochi, and K. Yamamoto. 2006. Interactions between IL-32 and tumor necrosis factor α contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res. Ther. 8: R166.
29. Calabrese, F., S. Baraldo, E. Bazzan, F. Lunardi, F. Rea, P. Maestrelli, G. Turato, K. Lokar-Oliani, A. Papi, R. Zuin, et al. 2008. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 178: 894-901.
30. Dinarello, C. A., and S. H. Kim. 2006. IL-32, a novel cytokine with a possible role in disease. Ann. Rheum. Dis. 65(Suppl. 3): iii61-iii64.
31. Alsaleh, G., L. Sparsa, E. Chatelus, M. Ehlinger, J. E. Gottenberg, D. Wachsmann, and J. Sibilia. 2010. Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res. Ther. 12: R135.
32. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
33. Gao, B., Y. Wang, and M. F. Tsan. 2006. The heat sensitivity of cytokine-inducing effect of lipopolysaccharide. J. Leukoc. Biol. 80: 359-366.
34. McGeachy, M. J., and D. J. Cua. 2008. Th17 cell differentiation: the long and winding road. Immunity 28: 445-453.
35. Fedele, G., F. Spensieri, R. Palazzo, M. Nasso, G. Y. Cheung, J. G. Coote, and C. M. Ausiello. 2010. Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways. PLoS ONE 5: e8734.
36. Kim, Y. S., S. W. Hong, J. P. Choi, T. S. Shin, H. G. Moon, E. J. Choi, S. G. Jeon, S. Y. Oh, Y. S. Gho, Z. Zhu, and Y. K. Kim. 2009. Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. J. Immunol. 183: 5113-5120.
37. Nasso, M., G. Fedele, F. Spensieri, R. Palazzo, P. Costantino, R. Rappuoli, and C. M. Ausiello. 2009. Genetically detoxified pertussis toxin induces Th1/Th17 immune response through MAPKs and IL-10-dependent mechanisms. J. Immunol. 183: 1892-1899.
38. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16: 495-521.
39. Adorini, L., F. Aloisi, F. Galbiati, M. K. Gately, S. Gregori, G. Penna, F. Ria, S. Smiroldo, and S. Trembleau. 1997. Targeting IL-12, the key cytokine driving Th1-mediated autoimmune diseases. Chem. Immunol. 68: 175-197.
40. Kang, J.-W., S.-C. Choi, M.-C. Cho, H.-J. Kim, J.-H. Kim, J.-S. Lim, S.-H. Kim, J.-Y. Han, and D.-Y. Yoon. 2009. A proinflammatory cytokine interleukin-32β promotes the production of an anti-inflammatory cytokine interleukin-10. Immunology 128: e532-e540.
41. Choi, J., S. Bae, J. Hong, S. Ryoo, H. Jhun, K. Hong, D. Yoon, S. Lee, E. Her, W. Choi, et al. 2010. Paradoxical effects of constitutive human IL-32γ in transgenic mice during experimental colitis. Proc. Natl. Acad. Sci. USA 107: 21082-21086.
42. Nastala, C. L., H. D. Edington, T. G. McKinney, H. Tahara, M. A. Nalesnik, M. J. Brunda, M. K. Gately, S. F. Wolf, R. D. Schreiber, W. J. Storkus, et al. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153: 1697-1706. (Pubitemid 24251114)
43. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90: 6115-6119.
44. Gavett, S. H., D. J. O'Hearn, X. Li, S. K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182: 1527-1536.
45. de Jong, E. C., H. H. Smits, and M. L. Kapsenberg. 2005. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26: 289-307.
46. Czerniecki, B. J., G. K. Koski, U. Koldovsky, S. Xu, P. A. Cohen, R. Mick, H. Nisenbaum, T. Pasha, M. Xu, K. R. Fox, et al. 2007. Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res. 67: 1842-1852. (Pubitemid 46383411)
47. - DC. J. Immunol. 177: 7067-7075.
48. Hokey, D. A., A. T. Larregina, G. Erdos, S. C. Watkins, and L. D. Falo Jr. 2005. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity. Cancer Res. 65: 10059-10067.
49. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13: 816-825.
50. Nold-Petry, C. A., M. F. Nold, J. A. Zepp, S. H. Kim, N. F. Voelkel, and C. A. Dinarello. 2009. IL-32-dependent effects of IL-1β on endothelial cell functions. Proc. Natl. Acad. Sci. USA 106: 3883-3888.
51. Zhong, H., R. E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1: 661-671. (Pubitemid 128379244)
52. Hou, C., T. Kirchner, M. Singer, M. Matheis, D. Argentieri, and D. Cavender. 2004. In vivo activity of a phospholipase C inhibitor, 1-(6-((17β-3-methoxyestra- 1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2, 5-dione (U73122), in acute and chronic inflammatory reactions. J. Pharmacol. Exp. Ther. 309: 697-704.
53. Novick,D.,M. Rubinstein,T.Azam,A.Rabinkov, C. A. Dinarello, andS.H.Kim. 2006. Proteinase 3 is an IL-32 binding protein. Proc. Natl. Acad. Sci. USA 103: 3316-3321.